Clinical Manifestations

Daniella Alicia Vellone1, Dylan X Guan1, Zahinoor Ismail1

  • 1Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Abstract

Insights

Mild Behavioral Impairment with apathy (MBI-apathy) is linked to brain atrophy in early Alzheimer's disease (AD) regions. This suggests MBI-apathy may indicate early AD changes, even before significant cognitive decline.

Area of Science:

  • Neuroscience
  • Gerontology
  • Neurology

Background:

  • Mild Behavioral Impairment (MBI) is a pre-dementia syndrome characterized by behavioral changes and a risk marker for cognitive decline.
  • The apathy domain of MBI is hypothesized to involve brain changes, but its relationship to apathy in dementia remains unclear.

Purpose of the Study:

  • To investigate volumetric brain differences between individuals with MBI-apathy and those without neuropsychiatric symptoms (No NPS).
  • To determine if MBI-apathy is associated with brain regions affected in early Alzheimer's disease (AD).

Main Methods:

  • Cross-sectional study of 446 participants from the National Alzheimer's Coordinating Center (NACC).
  • Group comparison between MBI-apathy (n=59) and No NPS (n=387) using linear regression.
  • Analysis of regional brain volumes and cortical thickness, including AD-related and apathy-related regions, adjusted for covariates.

Main Results:

  • MBI-apathy was significantly associated with lower average AD composite cortical thickness and total volume.
  • Individuals with MBI-apathy showed reduced thickness in the dorsolateral prefrontal cortex (dlPFC) and reduced volume in the orbitofrontal cortex (OFC) and dlPFC.

Conclusions:

  • MBI-apathy is associated with atrophy in brain regions typically affected early in AD.
  • These findings suggest MBI-apathy may reflect early AD-related brain changes in cognitively normal and mild cognitive impairment stages.
  • Apathy-related brain regions may be affected later in AD progression.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437